Clinical Trials Sponsored by Neuravi Inc.

Total 35552 results

Neuravi Inc.

Completed

Analysis of Revascularization in Ischemic Stroke With EmboTrap (ARISEII)

Ischemia | Stroke

Ireland, United States, Belgium, Germany
Neuravi Limited

Completed

Post Marketing Study to Evaluate the NIMBUS Device (SPERO)

Cerebral Stroke

Germany, Sweden
Neuravi Limited

Terminated

Analysis of Revascularisation in Ischemic Stroke With EmboTrap (ARISE)

Ischemic Stroke

Ireland, Denmark, Germany, Spain, Sweden
Neuraly, Inc.

Not yet recruiting

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NAFLD | NASH

United States
Neuraly, Inc.

Active, not recruiting

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

Parkinson Disease

United States, Canada
Neuraly, Inc.

Completed

A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

NAFLD | Overweight and Obesity | Type2 Diabetes

United States, Puerto Rico
Neuraly, Inc.

Completed

A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects (NLY01-H1)

Safety and Tolerability in Healthy Volunteers

United States
NeuroVia, Inc.

Withdrawn

Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy

X-Linked Adrenoleukodystrophy

Australia, Argentina, United Kingdom, Colombia, Chile, France, Russian Federation, Ukraine
NeuroVia, Inc.

Unknown

A Study to Prospectively Assess Disease Progression in Male Children With X-ALD

X-Linked Adrenoleukodystrophy

United States
Neuraly, Inc.

Completed

A Study With NLY01 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Type2 Diabetes

Germany
Neurana Pharmaceuticals, Inc.

Completed

A Phase 1 PK Study of Tolperisone in Healthy Subjects

Healthy

United States
Neurana Pharmaceuticals, Inc.

Completed

Effects of Tolperisone on Measures of Drowsiness and Cognitive Function

Healthy

United States
Neurana Pharmaceuticals, Inc.

Completed

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm (RESUME-1)

Back Pain | Acute Pain | Back Muscle Spasm | Back Strain | Back Spasm Upper | Muscle Spasm

United States
Neurana Pharmaceuticals, Inc.

Completed

Tolperisone in Acute Muscle Spasm of the Back (STAR)

Back Pain | Low Back Pain | Acute Pain | Muscle Cramp | Back Strain | Muscle Spasm | Back Spasm Upper Back

United States
Niguarda Hospital
Neuravi Limited

Recruiting

EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke

Acute Ischemic Stroke

Italy
NEURALIS s.a.

Recruiting

Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers

Pharmacokinetics | Safety

Bulgaria
NEURALIS s.a.

Active, not recruiting

Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

Covid19

Belgium, Hungary, Russian Federation, Poland
Neurana Pharmaceuticals, Inc.
Cognitive Research Corporation

Completed

Driving Simulation to Assess Non-Sedative Effects of Tolperisone

Driving Impaired

United States
Otto Bock France SNC
Euraxi Pharma

Completed

Compensatory Movements With Axon-Hook and Greifer in Transradial Amputees

Transradial Amputation

France
Nurami Medical Ltd

Completed

A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair. (NEOART)

Cerebrospinal Fluid Leak | Dural Tear

Spain, Belgium, Poland, Czechia, Israel
Danone Research
Euraxi Pharma

Active, not recruiting

Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

Gastro-intestinal Symptoms in Healthy Subjects

France
Nutricia Nutrition Clinique
Euraxi Pharma

Recruiting

Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance (KEOPS)

Drug Resistant Epilepsy | Ketogenic Dieting

France
Air Liquide Santé International
Euraxi Pharma

Completed

Study on the Use of Inhaled NO (iNO) (POSITIVE)

Pulmonary Hypertension

France, Belgium
ETH Zurich
Neural Control of Movement laboratory ETH Zurich

Recruiting

multiSENSory Stimulation to tArgeT Sensory Loss and chronIc Pain in neurOpathic patieNts (SENSATION)

Diabetic Neuropathies | Amputation | Neuropathy | Neuropathy, Painful | Sensory Neuropathy

Switzerland
Organ, Tissue, Regeneration, Repair and Replacement
European Commission; Euraxi Pharma

Active, not recruiting

An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS) (MATRISS)

Stroke, Acute

France
GCS Ramsay Santé pour l'Enseignement et la Recherche
Euraxi Pharma

Completed

Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery (INDEX)

Analgesia

France
Organ, Tissue, Regeneration, Repair and Replacement
Euraxi Pharma; ARANZ Medical

Recruiting

CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa (MATHBULL)

Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa, Junctional

France
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Eisai Inc.
Quintiles, Inc.

Terminated

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States, Australia, Russian Federation, India, Ukraine
AxeroVision, Inc.
ORA, Inc.

Completed

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

Dry Eye

United States
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Novan, Inc.
Synteract, Inc.

Completed

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Molluscum Contagiosum

United States

Clinical Trials Sponsored by Neuravi Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations